Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study - Lipton, Richard B.; Buse, Dawn C.; Sandoe, Claire H.; Ford, Janet H.; Hand, Austin L.; Jedynak, Jakub P.; Port, Martha D.; Detke, Holland C. (Headache, 2023)
Keywords: Adult; Antibodies, Monoclonal, Humanized - therapeutic use; calcitonin gene‐related peptide; chronic migraine; Clinical trials; Double-Blind Method; episodic migraine; Evaluation; Headache; Humans; interictal burden; Migraine; Migraine Disorders - drug therapy; migraine prevention; Monoclonal antibodies; Patients; Placebos; Treatment Outcome; calcitonin gene-related peptide; episodic migraine; migraine prevention; chronic migraine; interictal burden; monoclonal antibodies